Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hip Fractures
1 trial -
Tranexamic Acid 100Mg/Ml Inj Vil 10Ml
Hospital Authority, Hong Kong
Rotator Cuff Tears
1 trial -
Tranexamic acid (TXA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Blood Loss
1 trial -
Transesophageal echocardiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Critically Ill
1 trial -
Trolamine (Biafine)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Tumor Specific Antigen-loaded Dendritic Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tumor Gastric
1 trial -
UC-MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Novel Coronavirus Pneumonia
1 trial -
UE
The First People's Hospital of Lianyungang
Lung Cancer
1 trial -
Ulinastatin
The First People's Hospital of Lianyungang
Acute Respiratory Distress Syndrome
1 trial -
Ulinastatin and Thymosin Ξ±1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Dissection
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Umbilical cord serum eyedrops
Hospital Authority, Hong Kong
Recurrent Corneal Erosion
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urapidil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aging
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Use baby moisturizers by NeoChine
The First People's Hospital of Lianyungang
Neonatal Jaundice
1 trial -
Using medical biological glue for filling And Using the meniscus suture system
The First People's Hospital of Lianyungang
Unilateral Meniscus Tear of the Knee Joint
1 trial -
Usual care
Eye & ENT Hospital of Fudan University
Vestibular Disorder
1 trial -
Vaginal progesterone
Hospital Authority, Hong Kong
Preterm Birth
1 trial -
Valerian
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menopausal Women
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Vildagliptin 50 mg bid
The First People's Hospital of Lianyungang
Parkinson's Disease
1 trial -
Village doctor-led tailored health management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources